AstraZeneca PLC
27 February 2003
ASTRAZENECA ISSUES 2002 ANNUAL REPORT
AstraZeneca today published its Annual Report and Form 20-F for 2002. The
document is available on the company's website - www.astrazeneca.com, click on
Investor Relations - Financial Reports.
In addition to the annual report, all shareholders will, for the first time,
receive a copy of AstraZeneca's 2002 Summary Corporate Responsibility Report,
which provides the main points of the company's approach to corporate
responsibility as well as 2002 performance highlights. Detailed statistics and
further information about our policies and commitment to corporate
responsibility are available on our web site - www.astrazeneca.com, click on
About Us - Corporate Responsibility.
27 February 2003
Media Enquiries:
Emily Denney, Tel: +44 (0) 207 304 5034
Steve Brown, Tel: +44 (0) 207 304 5033
Investor Relations:
Mina Blair Robinson, Tel: +44 (0) 207 304 5084
Jonathan Hunt, Tel: +44 (0) 207 304 5087
- Ends -
This information is provided by RNS
The company news service from the London Stock Exchange
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.